Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease

Simple item page
dc.citation.articleNumber1106315
dc.citation.journalTitleFrontiers in Cellular and Infection Microbiology
dc.citation.volumeNumber13
dc.contributor.authorJones, Kathryn M.
dc.contributor.authorMangin, Elise N.
dc.contributor.authorReynolds, Corey L.
dc.contributor.authorVillanueva, Liliana E.
dc.contributor.authorCruz, Julio Vladimir
dc.contributor.authorVersteeg, Leroy
dc.contributor.authorKeegan, Brian
dc.contributor.authorKendricks, April
dc.contributor.authorPollet, Jeroen
dc.contributor.authorGusovsky, Fabian
dc.contributor.authorBottazzi, Maria Elena
dc.contributor.authorHotez, Peter J.
dc.contributor.orgJames A. Baker III Institute for Public Policy
dc.date.accessioned2023-03-10T19:04:14Z
dc.date.available2023-03-10T19:04:14Z
dc.date.issued2023
dc.description.abstractIntroduction: Chagas disease, caused by chronic infection with the protozoan parasite Trypanosoma cruzi, affects 6-7 million people worldwide. The major clinical manifestation of Chagas disease is chronic Chagasic cardiomyopathy (CCC), which encompasses a spectrum of symptoms including arrhythmias, hypertrophy, dilated cardiomyopathy, heart failure, and sudden death. Current treatment is limited to two antiparasitic drugs, benznidazole (BNZ) and nifurtimox, but both have limited efficacy to halt the progression of CCC. We developed a vaccine-linked chemotherapy strategy using our vaccine consisting of recombinant Tc24-C4 protein and a TLR-4 agonist adjuvant in a stable squalene emulsion, in combination with low dose benznidazole treatment. We previously demonstrated in acute infection models that this strategy parasite specific immune responses, and reduced parasite burdens and cardiac pathology. Here, we tested our vaccine-linked chemotherapy strategy in a mouse model of chronic T. cruzi infection to evaluate the effect on cardiac function.Methods: Female BALB/c mice infected with 500 blood form T. cruzi H1 strain trypomastigotes were treated beginning 70 days after infection with a low dose of BNZ and either low or high dose of vaccine, in both sequential and concurrent treatments streams. Control mice were untreated, or administered only one treatment. Cardiac health was monitored throughout the course of treatment by echocardiography and electrocardiograms. Approximately 8 months after infection, endpoint histopathology was performed to measure cardiac fibrosis and cellular infiltration.ResultsVaccine-linked chemotherapy improved cardiac function as evidenced by amelioration of altered left ventricular wall thickness, left ventricular diameter, as well as ejection fraction and fractional shortening by approximately 4 months of infection, corresponding to two months after treatment was initiated. At study endpoint, vaccine-linked chemotherapy reduced cardiac cellular infiltration, and induced significantly increased antigen specific IFN-γ and IL-10 release from splenocytes, as well as a trend toward increased IL-17A.Discussion: These data suggest that vaccine-linked chemotherapy ameliorates changes in cardiac structure and function induced by infection with T. cruzi. Importantly, similar to our acute model, the vaccine-linked chemotherapy strategy induced durable antigen specific immune responses, suggesting the potential for a long lasting protective effect. Future studies will evaluate additional treatments that can further improve cardiac function during chronic infection.
dc.identifier.citationJones, Kathryn M., Mangin, Elise N., Reynolds, Corey L., et al.. "Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease." <i>Frontiers in Cellular and Infection Microbiology,</i> 13, (2023) Frontiers: https://doi.org/10.3389/fcimb.2023.1106315.
dc.identifier.digitalfcimb-13-1106315
dc.identifier.doihttps://doi.org/10.3389/fcimb.2023.1106315
dc.identifier.urihttps://hdl.handle.net/1911/114502
dc.language.isoeng
dc.publisherFrontiers
dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleVaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpublisher version
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
fcimb-13-1106315.pdf
Size:
11.46 MB
Format:
Adobe Portable Document Format
Download
Collections
Faculty Publications